While most providers hold largely positive views of telehealth for MOUD, hesitation towards telehealth is linked to assumptions about the broader empirical state of in-person MOUD treatment and about patient needs, preferences, and capacities to engage in care. Learn more about this study from Shoshana Aronowitz, Naomi Zucker, and colleagues.
Provider Perspectives on Telehealth for Buprenorphine Access
